Compare Abeona Therapeutics Inc (ABEO) vs SpaceX (SPCX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Abeona Therapeutics Inc vs SpaceX — how do they compare? Abeona Therapeutics Inc trades at $7.44 (market cap $421.19M), while SpaceX trades at $136.61 (market cap $1.76T). The key difference: SpaceX is far larger — about 4178.6× Abeona Therapeutics Inc's market cap, and Abeona Therapeutics Inc is trading nearer its 52-week high, SpaceX nearer its low. Which is the better fit depends on your goals.
| ABEO | SPCX | |
|---|---|---|
Market Cap | $421.19M | $1.76T |
Sector | Health | Technology |
52-Week High | $7.45 | $202.09 |
52-Week Low | $4.17 | $108.27 |
Enterprise Value | $276.10M | $1.70T |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Abeona Therapeutics Inc
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →About SpaceX
SpaceX is the world's leading aerospace manufacturer and launch provider. It designs and operates reusable rockets, spacecraft, and Starlink, a global satellite internet service with over 10 million subscribers across 160 countries.
Read more on SPCX →
